CTDT Centaurus Diamond Technologies Inc (CE)

CENTAURUS DIAMOND TECHNOLOGIES INC., (The "Company" or "Centaurus") (OTCQB: CTDT) and (PINKSHEETS: CTDT) Centaurus announces it has now entered the first phase of its proprietary Magnatech process, wherein specifications and guidelines are established for the commercial mass production of industrial diamonds.

Further, we are advancing the limits our equipment can endure and what those limits mean to our manufactured diamond's structure and quality. Centaurus has purchased the test materials to be used in Phase One of the mass production process.

Throughout experimental Phase One it is the Company's goal to master the exact methodology of mass producing diamonds and essentially obtain those specifications that can assure maximum efficiency of the Magnatech diamond synthesis process.

Centaurus Diamond Technologies Inc. Centaurus has been established to fully commercialize its proprietary, cost-efficient and high-volume diamond production method to provide industrial quality diamonds. The Company's patented technology enables the production of "cultured" diamonds that are chemically, atomically, and structurally identical to natural diamonds. The Gemological Institute of America has tested the Company's lab-created diamonds and has confirmed they are diamonds according to their testing protocols.

Safe Harbor Statement This press release may contain certain "forward-looking statements" relating to the business of Centaurus Diamond Technologies, Inc. and its subsidiary companies. All statements, other than statements of historical fact included herein are "forward-looking statements." These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions, involve known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in the Company's periodic reports that are filed with the Securities and Exchange Commission and available on its website at http://www.sec.gov. All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.

For further information, please contact: American Capital Ventures Tel: 1-305-918-7000